In recent years progress has been made in developing cancer immunotherapies that target specific aspects of an individual’s tumour.
moreIntroducing cancer immunotherapy
Beyond the immunity cycle
Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.
Collaboration in research
Cancer remains one of the leading causes of death worldwide, but world-class research provides hope.
moreAbout bladder cancer
Bladder cancer is one of the top ten most common cancers in the world.
moreBladder cancer: the symptoms you shouldn’t ignore
One patient shares his experience being diagnosed with a disease he knew nothing about.
moreChanging the colorectal cancer story
Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.
more
A pocket guide to interpreting data
Obtain simple definitions of clinical terms with our pocket guide to interpreting data.
Downloads: Download
Potential pathways
Learn about some of the different ways we can harness the power of our immune system to fight cancer.
moreLinking T-cells and cancer cells
When the body’s own immune system fails, T-cell bispecific antibodies help T-cells spring back into action and attack cancer cells.
CEO on cancer immunotherapy
Roche CEO Severin Schwan talks about our commitment and leadership in this exciting field.
Rewriting the book on immunotherapy
Learn how biomarkers take the stage in helping doctors diagnose cancer.
moreThe PD-L1 pathway
The role of the immune system is to protect the body from foreign invaders. PD-L1 can help tumour cells evade the immune surveillance.
Unleashing the T-Cell army
Learn how our research and development team managed to separate 200 known cancer types into three primary immune profiles.